# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-25-105183
Filing Date
2025-11-03
Accepted
2025-11-03 16:02:02
Documents
27
Period of Report
2025-12-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROXY STATEMENT | ea0261240-03.htm iXBRL | DEF 14A | 1108457
6 | GRAPHIC | tbarchart_001.jpg | GRAPHIC | 583510
7 | GRAPHIC | tbarchart_002.jpg | GRAPHIC | 542985
8 | GRAPHIC | timage_001.jpg | GRAPHIC | 21254
9 | GRAPHIC | timage_002.jpg | GRAPHIC | 12342
10 | GRAPHIC | timage_003.jpg | GRAPHIC | 21198
11 | GRAPHIC | timage_004.jpg | GRAPHIC | 1611929
12 | GRAPHIC | timage_005.jpg | GRAPHIC | 1491350
13 | GRAPHIC | tmarlan_sig.jpg | GRAPHIC | 14305
14 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 1528384
15 | GRAPHIC | tproxy_002.jpg | GRAPHIC | 1042022
16 | GRAPHIC | ttherapeuticsmd_logo.jpg | GRAPHIC | 38886
| Complete submission text file | 0001213900-25-105183.txt |  | 18949554

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL SCHEMA FILE | txmd-20251103.xsd | EX-101.SCH | 14075
3 | XBRL DEFINITION FILE | txmd-20251103_def.xml | EX-101.DEF | 9603
4 | XBRL LABEL FILE | txmd-20251103_lab.xml | EX-101.LAB | 45182
5 | XBRL PRESENTATION FILE | txmd-20251103_pre.xml | EX-101.PRE | 14279
29 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0261240-03_htm.xml | XML | 492539

Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-00100 | Film No.: 251443958
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)